Skip to content

Clinical trials

Phase 3 Agnosia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Agnosia Phase: Phase 3 Country / region: United States Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20073
20083
20112
20125
20132
20141
20153
20166
20176
20183
20193
20204
202113
20224
20243
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting12
Terminated8
Active, not recruiting4
Withdrawn4
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baudax Bio5
Pacira Pharmaceuticals, Inc4
Stanford University4
Avenue Therapeutics, Inc.3
Emory University3
Heron Therapeutics2
Hospital for Special Surgery, New York2
Innocoll2
Major Extremity Trauma Research Consortium2
Memorial Sloan Kettering Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Agnosia72
Pain22
Postoperative Pain18
Anemia, Sickle Cell3
Breast Neoplasms2
Chronic Pain2
Hernia2
Liver Neoplasms2
Low Back Pain2
Tibial Fractures2

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.